Also, this group demonstrated that TCGA BLCA patients with increased APOBEC mutagenesis had significantly improved survival, and that the tumours from patients homozygous for the rs17000526-A allele were enriched for TP53 and PIK3CA mutations [134] (figure 5). The gene discussed is TP53; the disease is bladder transitional cell carcinoma.